Ismail Hdoufane

10PUBLICATIONS
23CO-AUTHORS
Medical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsBioavailability and ecotoxicologyBiomolecular modelling and designMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 15, 2026
Computational Repurposing of FDA-Approved Drugs as Candidate MMP2 Inhibitors with Putative MMP3 Cross-Activity.

|Aug 27, 2026
Correction: Tber et al. Pyrido[2',1':2,3]imidazo[4,5-c]isoquinolin-5-amines as Potential Cytotoxic Agents Against Human Neuroblastoma. Pharmaceuticals 2021, 14, 750.

|Jun 25, 2026
Algicidal Monoterpenes Against Toxin-Producing Microcystis aeruginosa with Reduced Toxicity Toward Chlorella sorokiniana: In Vitro, Molecular Docking, and ADMET Study.

|Dec 23, 2023
Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants.

Mohamed Adardour, Marouane Ait Lahcen, Mehdi Oubahmane

|Apr 28, 2023
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations.

Mehdi Oubahmane, Ismail Hdoufane, Christelle Delaite

|Sep 23, 2022
Hybrid Molecules as Potential Drugs for the Treatment of HIV: Design and Applications.

Wissal Liman, Nouhaila Ait Lahcen, Mehdi Oubahmane

Pageof 2

Frequent Collaborators

6 joint publications

Mehdi Oubahmane

3 joint publications

Achraf El Allali

2 joint publications

Imane Bjij

2 joint publications

Mohammed Loubidi